149 related articles for article (PubMed ID: 7250175)
1. First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.
Abshagen U; Spörl-Radun S
Eur J Clin Pharmacol; 1981; 19(6):423-9. PubMed ID: 7250175
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained-release formulations of isosorbide dinitrate in normal man.
Johnson KI; Gladigau V; Schnelle K
Arzneimittelforschung; 1981; 31(6):1026-9. PubMed ID: 7196234
[TBL] [Abstract][Full Text] [Related]
3. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.
Abshagen U; Betzien G; Endele R; Kaufmann B
Eur J Clin Pharmacol; 1981; 20(4):269-75. PubMed ID: 7308280
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
6. Effects and pharmacokinetics of isosorbide dinitrate in normal man.
Spörl-Radun S; Betzien G; Kaufmann B; Liede V; Abshagen U
Eur J Clin Pharmacol; 1980 Oct; 18(3):237-44. PubMed ID: 7439242
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the initial hemodynamic effects of immediate-release versus sustained-release isosorbide-5-mononitrate following single oral doses.
Trenk D; Hinder M; Stengele E; Bonn R; Jähnchen E
J Clin Pharmacol; 2000 Feb; 40(2):168-76. PubMed ID: 10664923
[TBL] [Abstract][Full Text] [Related]
8. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
Geigenberger A; Degen J; Maier-Lenz H
Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
[TBL] [Abstract][Full Text] [Related]
10. [Bioavailability of isosorbide dinitrate and isosorbide-5-mononitrate under steady-state conditions].
Rietbrock N; Knoll J; Merz PG; Menke G
Dtsch Med Wochenschr; 1985 Nov; 110(47):1821-5. PubMed ID: 3905327
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics of low-dose isosorbide dinitrate and metabolites after buccal or oral administration].
Keller-Stanislawski B; Marschner JP; Rietbrock N
Arzneimittelforschung; 1992 Jan; 42(1):17-20. PubMed ID: 1586374
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
13. Influence of diet on the single-dose pharmacokinetics of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate.
Sata H; Inoue K; Nii T; Kuroda T
Biol Pharm Bull; 1997 Oct; 20(10):1111-5. PubMed ID: 9353575
[TBL] [Abstract][Full Text] [Related]
14. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
16. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
Straehl P; Galeazzi RL; Soliva M
Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
[TBL] [Abstract][Full Text] [Related]
17. [Bioavailability and bioequivalence of organic nitrates. Isosorbide dinitrate--a study of sustained-release preparations].
Scheidel B; Blume H; Stenzhorn G; Siewert M; Babej-Dölle RM
Arzneimittelforschung; 1991 Mar; 41(3):212-8. PubMed ID: 1867657
[TBL] [Abstract][Full Text] [Related]
18. [Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].
Leitold M; Laufen H
Arzneimittelforschung; 1983; 33(8):1117-21. PubMed ID: 6685489
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.
Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N
Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111
[TBL] [Abstract][Full Text] [Related]
20. Absorption and excretion of isosorbide dinitrate and isosorbide-2-mononitrate in dogs.
Cayen MN; Hicks D; Karounis J; Dvornik D
J Pharm Pharmacol; 1983 May; 35(5):312-6. PubMed ID: 6134800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]